Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By : Type (Pediatric Hepatitis B (CHO) Vaccine, Adult Hepatitis B (CHO) Vaccine); Application (Hospitals, Clinics)

Report Code: TIPRE00017829 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Chinese Hamster Ovary (CHO) cells, have been widely used to produce vaccines as it gives higher levels of stability and less concerns of sterility. Recombinant vaccines are free of blood contaminants and thus have gained tremendous popularity. With the help of expression vectors the HBsAg gene has been inserted into Chinese hamster ovary (CHO) cells to produce hepatitis B vaccines.

MARKET DYNAMICS

The recombinant hamster ovary cell (CHO) hepatitis B vaccine market is driving due to the growing prevalence of hepatitis B across the globe, increasing government support to promote (CHO) hepatitis B vaccination and extensive research and development on hepatitis vaccines. However, disadvantages of using recombinant Chinese hamster ovary cell (CHO) is likely to hamper the growth of the market.

MARKET SCOPE

The "Recombinant hamster ovary cell (CHO) hepatitis B vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of recombinant hamster ovary cell (CHO) hepatitis B vaccine market with detailed market segmentation by type and application. The recombinant hamster ovary cell (CHO) hepatitis B vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Recombinant hamster ovary cell (CHO) hepatitis B vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The recombinant hamster ovary cell (CHO) hepatitis B vaccine market is segmented on the basis of type and application. Based on type, the market is segmented as pediatric hepatitis B (CHO) vaccine and adult hepatitis B (CHO) vaccine. The application segment is divided into hospitals and clinics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the recombinant hamster ovary cell (CHO) hepatitis B vaccine Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant hamster ovary cell (CHO) hepatitis B vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting recombinant hamster ovary cell (CHO) hepatitis B vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the recombinant hamster ovary cell (CHO) hepatitis B vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Recombinant hamster ovary cell (CHO) hepatitis B vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Recombinant hamster ovary cell (CHO) hepatitis B vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for recombinant hamster ovary cell (CHO) hepatitis B vaccine in the global market. Below mentioned is the list of few companies engaged in the recombinant hamster ovary cell (CHO) hepatitis B vaccine market.

The report also includes the profiles of key players in recombinant hamster ovary cell (CHO) hepatitis B vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck and Co., Inc.
  •   GlaxoSmithKline Plc
  •   Pfizer Inc.
  •   Sanofi Pasteur
  •   CSL Limited
  •   Emergent Biosolutions
  •   Serum Institute of India
  •   Johnson and Johnson

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market - By Type
1.3.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market - By Application
1.3.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PEDIATRIC HEPATITIS B (CHO) VACCINE
7.3.1. Overview
7.3.2. Pediatric Hepatitis B (CHO) Vaccine Market Forecast and Analysis
7.4. ADULT HEPATITIS B (CHO) VACCINE
7.4.1. Overview
7.4.2. Adult Hepatitis B (CHO) Vaccine Market Forecast and Analysis
8. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
9. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
9.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis
9.1.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Type
9.1.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Application
9.1.5 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.1.5.1.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.1.5.1.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.1.5.2 Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.1.5.2.1 Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.1.5.2.2 Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.1.5.3 Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.1.5.3.1 Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.1.5.3.2 Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.2. EUROPE
9.2.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
9.2.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis
9.2.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Type
9.2.4 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Application
9.2.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.2.5.1.1 Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.2.5.1.2 Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.2.5.2 France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.2.5.2.1 France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.2.5.2.2 France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.2.5.3 Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.2.5.3.1 Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.2.5.3.2 Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.2.5.4 Spain Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.2.5.4.1 Spain Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.2.5.4.2 Spain Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.2.5.5 United Kingdom Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.2.5.5.1 United Kingdom Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.2.5.5.2 United Kingdom Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.2.5.6 Rest of Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.2.5.6.1 Rest of Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.2.5.6.2 Rest of Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
9.3.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.3.5.1.1 Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.3.5.1.2 Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.3.5.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.3.5.2.1 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.3.5.2.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.3.5.3 India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.3.5.3.1 India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.3.5.3.2 India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.3.5.4 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.3.5.4.1 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.3.5.4.2 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.3.5.5 South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.3.5.5.1 South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.3.5.5.2 South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.3.5.6 Rest of Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.3.5.6.2 Rest of Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
9.4.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.4.5.1.1 South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.4.5.1.2 South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.4.5.2 Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.4.5.2.1 Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.4.5.2.2 Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.4.5.3 U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.4.5.3.1 U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.4.5.3.2 U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.4.5.4 Rest of Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.4.5.4.2 Rest of Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
9.5.2 South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.5.5.1.1 Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.5.5.1.2 Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.5.5.2 Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.5.5.2.1 Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.5.5.2.2 Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
9.5.5.3 Rest of South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
9.5.5.3.1 Rest of South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
9.5.5.3.2 Rest of South and Central America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RECOMBINANT HAMSTER OVARY CELL (CHO) HEPATITIS B VACCINE MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI PASTEUR
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CSL LIMITED
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EMERGENT BIOSOLUTIONS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SERUM INSTITUTE OF INDIA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JOHNSON AND JOHNSON
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Merck and Co., Inc.
2. GlaxoSmithKline Plc
3. Pfizer Inc.
4. Sanofi Pasteur
5. CSL Limited
6. Emergent Biosolutions
7. Serum Institute of India
8. Johnson and Johnson
TIPRE00017829
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking